StonvexLoading…
StonvexStonvexStonvexCore line items from DHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-29 |
|---|---|---|---|---|
Revenue | $24.57B | $23.88B | $23.89B | $5.62B |
Operating Income | $4.69B | $4.86B | $5.20B | $1.19B |
Net Income | $3.61B | $3.90B | $4.76B | $1.13B |
EPS (Diluted) | $5.05 | $5.29 | $6.38 | $1.51 |
Total Assets | $83.46B | $77.54B | $84.49B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.62B | $2.08B | $5.86B | Not available |
Free Cash Flow OCF − CapEx | $5.26B | $5.30B | $5.78B | Not available |
Shares Outstanding | 706.90M | 719.10M | 739.20M | Not available |